Healthpeak Properties, Inc. with ticker code (PEAK) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 33 and 22 suggesting an average Analsyt target price of $26.00. Given that the stocks previous close was at $20.10 and the analysts are correct then there would likely be a percentage uptick in value of 29.4%. There is a 50 day moving average of $21.12 and the 200 moving average now moves to $24.27. The market cap for the company is 11.02B. The stock price for Iron Mountain Incorporated is 20.15 USD
The potential market cap would be $14,257,272,537 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 19.95, revenue per share of 3.86 and a 1.42% return on assets.
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. It owns and develops high-quality real estate in the three private-pay healthcare asset classes of life science, medical office, and continuing care retirement communities (CCRCs). The Company operates through two segments: Life science, and Medical office. The Company’s Life Science segment properties contain laboratory and office space, which are leased primarily to biotechnology, medical device, and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Company’s Medical Office segment includes medical office buildings (MOBs) and hospitals. MOBs typically contain physicians’ offices and examination rooms, and may also include pharmacies, hospital ancillary service space, and outpatient services.
